C-8 Medical Monitoring Program
Welcome to the C-8 Medical Monitoring Program Website
Follow Up Screening Alert:
A settlement in the class action, Jack Leach et al. v. E.I. du Pont de Nemours and Co., Civil Action No. 01-C-608, was approved by the West Virginia Circuit Court in February 2005 (the "Settlement"). The class action is related to the release of a chemical known as ammonium perfluorooctanate (hereinafter "C-8"), attributable to releases from DuPont's Washington Works Plant in Wood County, West Virginia, into human drinking water supplies in certain specified areas.
As part of the Settlement, Class Counsel and DuPont mutually agreed upon an independent three-member scientific panel (the "Science Panel") to
conduct and evaluate studies to answer the question whether there is a "Probable Link" between C-8 exposure and any Human Disease. The Settlement Agreement
defines Probable Link to mean that, based upon the weight of the available scientific evidence, it is more likely than not that there is a link between exposure
to C-8 and a particular Human Disease among Class Members. After lengthy studies, in which many Class Members participated, the Science Panel found that there
is a Probable Link between exposure to C-8 and the following Human Diseases.
- pregnancy-induced hypertension (including preeclampsia),
- kidney cancer,
- testicular cancer,
- thyroid disease,
- ulcerative colitis, and
- high cholesterol (hypercholesterolemia).
The Science Panel did not find that a Probable Link exists for any other Human Disease. As called for by the Settlement, the parties mutually agreed upon an independent panel of three medical doctors (the "Medical Panel") to develop general guidelines for Medical Monitoring that is related to the Human Diseases for which the Science Panel delivered a Probable Link Finding and is different from what would otherwise be prescribed for Class Members absent exposure to C-8 ("Medical Monitoring Protocol.") The Medical Panel has now released a Medical Monitoring Protocol identifying initial recommended medical monitoring procedures for Class Members for each of these Human Diseases. Information on these medical monitoring procedures can be found in the Medical Panel's Information on the C-8 Medical Monitoring Program Screening Tests document on the Important Legal and Other Documents tab. The Medical Panel will issue an additional Protocol specifying the frequency and duration of the recommended tests and Class Members will receive an additional notice addressing these issues when that additional Protocol is issued.
If you believe you may be a Class Member and would like to obtain medical monitoring, you should fill out the Class Member Registration and Eligibility Form. This form may be completed online through the website or by downloading and printing the form for mailing to the Medical Monitoring Administrator at the address listed below and on the form. The Medical Monitoring Administrator will promptly determine if you are an eligible Class Member. If you are an eligible Class Member, you will receive a package of information containing detailed information explaining what steps you should take to participate in and receive medical monitoring as established by the Medical Monitoring Program.
Toll Free Number 1-888-499-2553
Available Monday - Friday 9:00AM - 9:00PM EST.
C-8 Medical Monitoring Program
PO Box 10030
Dublin, Ohio 43017-6630